Nahndi Bush, MD
Ophthalmology · Irvington, NJNPI 1568504280
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $21,417 of the $24,257 with a category attached, or 88.3%. It is spread thinly across 30 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Among ophthalmology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 356 payments — averaging $68.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$5K
- AbbVie$4K
- Johnson & Johnson Surgical Vision, Inc.$2K
- Alcon$2K
- Sight Sciences, Inc.$2K
- NEW World Medical,inc.$2K
- plus $7K from 24 others
What the payments were for
- Consulting fees$1,6507%
- Travel & lodging$1,1455%
- Food & beverage$21,41788%
- Gifts$450%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 29 | $5,222 |
| AbbVie(2 entities) | 106 | $3,926 |
| Johnson & Johnson Surgical Vision, Inc. | 16 | $2,455 |
| Alcon | 51 | $2,255 |
| Sight Sciences, Inc. | 20 | $1,906 |
| NEW World Medical,inc. | 9 | $1,641 |
| Bausch & Lomb Americas Inc. | 27 | $1,310 |
| Aerie Pharmaceuticals, Inc. | 13 | $774 |
| Ivantis, Inc | 5 | $610 |
| Oyster Point Pharma, Inc. | 8 | $442 |
| Eyevance Pharmaceuticals LLC | 6 | $434 |
| Sun Pharmaceutical Industries Inc. | 4 | $382 |
| Dompe US, Inc. | 5 | $337 |
| Biotissue Holdings Inc. | 8 | $332 |
| Mallinckrodt Hospital Products Inc. | 10 | $272 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $265 |
| Rxsight Inc | 2 | $248 |
| Ocular Therapeutix, Inc. | 8 | $199 |
| Amgen(2 entities) | 2 | $193 |
| Tarsus Pharmaceuticals, Inc. | 3 | $162 |
| Harrow Eye, LLC | 3 | $155 |
| Astellas Pharma US Inc | 1 | $135 |
| Lumenis BE Inc | 1 | $134 |
| Rayner Intraocular Lenses Limited | 1 | $125 |
| Kala Pharmaceuticals, Inc. | 1 | $119 |
| Pfizer | 1 | $69 |
| Novartis | 5 | $69 |
| Shire North American Group Inc | 3 | $42 |
| Omeros Corporation | 1 | $30 |
| Travere Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis 1-piece IOL$1,490
- Tecnis Multifocal Family of 1-piece IOLS$1,394
- Tecnis Symfony IOL$1,269
- OMNI(R) SURGICAL SYSTEM (US)$1,200
- DURYSTA$1,093
- Ahmed Glaucoma Valve$1,031
- Kahook Dual Blade$1,031
- SION SURGICAL INSTRUMENT$916
- Hydrus Microstent$853
- Streamline Surgical System$806
- Rhopressa$726
- Rocklatan$726
- iStent inject Trabecular Micro-Bypass Stent System$692
- iDose$573
- Tecnis IOL$530
- enVista MX60 IOL$493
- VYZULTA$469
- Hydrus$422
- Photrexa$403
- Clareon$392
How this compares
$24,257 in reported general payments places this provider in the 95th percentile of 583 ophthalmology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 211 | $245,477 |
| LumiganBimatoprost | 229 | $126,469 |
| RocklatanNetarsudil Mesylat/Latanoprost | 187 | $100,520 |
| CombiganBrimonidine Tartrate/Timolol | 223 | $85,993 |
| VyzultaLatanoprostene Bunod | 170 | $65,203 |
| XiidraLifitegrast | 53 | $65,152 |
| MieboPerfluorohexyloctane/Pf | 64 | $64,425 |
| Cyclosporine | 69 | $27,910 |
| Alphagan PBrimonidine Tartrate | 68 | $22,979 |
| ProlensaBromfenac Sodium | 50 | $16,579 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 78 | $15,216 |
| Bromfenac Sodium | 58 | $12,012 |
| RhopressaNetarsudil Mesylate | 20 | $9,193 |
| Latanoprost | 926 | $6,769 |
| Methazolamide | 22 | $6,220 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P, Restasis Multidose | $3,926 | $486,499743 claims |
| Bausch & Lomb Americas Inc.Vyzulta, Xiidra, Miebo | $1,310 | $194,780287 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $774 | $109,713207 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Loteprednol Etabonate | $265 | $20,07977 claims |
| AlconSimbrinza | $2,255 | $5,24326 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 583 ophthalmology providers in New Jersey.
Other ophthalmology in Irvington
- Jai ParekhWoodland Park$2M
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Cynthia MatossianPennington$655K
- Eric MannDover$604K
- Brett BieloryRutherford$477K
- Albert KhouriNewark$428K
- Robert FechtnerNewark$324K
- Rajen DesaiFreehold$311K
- Douglas GraysonIselin$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.